title: Acute-Phase Deaths from Murine Polymicrobial Sepsis Are Characterized by Innate Immune Suppression Rather Than Exhaustion.
abstract: Sepsis, a leading cause of death in the United States, has poorly understood mechanisms of mortality. To address this, our model of cecal ligation and puncture (CLP) induced sepsis stratifies mice as predicted to Live (Live-P) or Die (Die-P) based on plasma IL-6. Six hours post-CLP, both Live-P and Die-P groups have equivalent peritoneal bacterial colony forming units and recruitment of phagocytes. By 24 h, however, Die-P mice have increased bacterial burden, despite increased neutrophil recruitment, suggesting Die-P phagocytes have impaired bacterial killing. Peritoneal cells were used to study multiple bactericidal processes: bacterial killing, reactive oxygen species (ROS) generation, and phagocytosis. Total phagocytosis and intraphagosomal processes were determined with triple-labeled Escherichia coli, covalently labeled with ROS- and pH-sensitive probes, and an ROS/pH-insensitive probe for normalization. Although similar proportions of Live-P and Die-P phagocytes responded to exogenous stimuli, Die-P phagocytes showed marked deficits in all parameters measured, thus suggesting immunosuppression rather than exhaustion. This contradicts the prevailing sepsis paradigm that acute-phase sepsis deaths (<5 d) result from excessive inflammation, whereas chronic-phase deaths (>5 d) are characterized by insufficient inflammation and immunosuppression. These data suggest that suppression of cellular innate immunity in sepsis occurs within the first 6 h.
authors.affiliation: Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA 02118;
authors.forename: Evan L
authors.initials: EL
authors.lastname: Chiswick
authors.affiliation: Department of Surgery, Boston University Medical Center, Boston, MA 02118; and.
authors.forename: Juan R
authors.initials: JR
authors.lastname: Mella
authors.affiliation: Division of Pulmonary, Allergy, and Critical Care Medicine, Boston University Medical Center, Boston, MA 02118.
authors.forename: John
authors.initials: J
authors.lastname: Bernardo
authors.affiliation: Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA 02118; remickd@bu.edu.
authors.forename: Daniel G
authors.initials: DG
authors.lastname: Remick
mesh_terms: D000210:Acute-Phase Reaction / Q000276:immunology* / Q000473:pathology; D000818:Animals; D004926:Escherichia coli / Q000276:immunology*; D004927:Escherichia coli Infections / Q000276:immunology* / Q000473:pathology; D005260:Female; D015850:Interleukin-6 / Q000276:immunology; D051379:Mice; D008813:Mice, Inbred ICR; D010587:Phagocytosis; D017382:Reactive Oxygen Species / Q000276:immunology*; D018805:Sepsis / Q000276:immunology* / Q000473:pathology
chemical_list: D015850:Interleukin-6; D017382:Reactive Oxygen Species